- HS •
- 29 September, 2026 •
- •
Emapalumab in Treatment-Experienced Primary HLH: Safety, Efficacy, and Transplant Outcomes from the Open-Label, Single-Arm Post-Authorization Study Sobi.EMAPALUMAB-104 in Chinese Patients
Rui Zhang, Xiaowen Zhai, Jianpei Fang, Andrew Danquah, Ben Peace, Per Hedlund, Andrew Ramsey, Rafael Krmar, Brian D. Jamieson